rs3795575

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000537.4(REN):​c.961-43C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.132 in 1,542,266 control chromosomes in the GnomAD database, including 14,039 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.14 ( 1585 hom., cov: 32)
Exomes 𝑓: 0.13 ( 12454 hom. )

Consequence

REN
NM_000537.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.267

Publications

18 publications found
Variant links:
Genes affected
REN (HGNC:9958): (renin) This gene encodes renin, an aspartic protease that is secreted by the kidneys. Renin is a part of the renin-angiotensin-aldosterone system involved in regulation of blood pressure, and electrolyte balance. This enzyme catalyzes the first step in the activation pathway of angiotensinogen by cleaving angiotensinogen to form angiotensin I, which is then converted to angiotensin II by angiotensin I converting enzyme. This cascade can result in aldosterone release, narrowing of blood vessels, and increase in blood pressure as angiotension II is a vasoconstrictive peptide. Transcript variants that encode different protein isoforms and that arise from alternative splicing and the use of alternative promoters have been described, but their full-length nature has not been determined. Mutations in this gene have been shown to cause hyperuricemic nephropathy familial juvenile 2, familial hyperproreninemia, and renal tubular dysgenesis. [provided by RefSeq, May 2020]
REN Gene-Disease associations (from GenCC):
  • familial juvenile hyperuricemic nephropathy type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
  • renal tubular dysgenesis of genetic origin
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 1-204155961-G-A is Benign according to our data. Variant chr1-204155961-G-A is described in CliVar as Benign. Clinvar id is 1236555.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-204155961-G-A is described in CliVar as Benign. Clinvar id is 1236555.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-204155961-G-A is described in CliVar as Benign. Clinvar id is 1236555.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-204155961-G-A is described in CliVar as Benign. Clinvar id is 1236555.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-204155961-G-A is described in CliVar as Benign. Clinvar id is 1236555.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.162 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RENNM_000537.4 linkc.961-43C>T intron_variant Intron 8 of 9 ENST00000272190.9 NP_000528.1 P00797-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RENENST00000272190.9 linkc.961-43C>T intron_variant Intron 8 of 9 1 NM_000537.4 ENSP00000272190.8 P00797-1
RENENST00000638118.1 linkc.847-43C>T intron_variant Intron 10 of 11 5 ENSP00000490307.1 A0A1B0GUZ2

Frequencies

GnomAD3 genomes
AF:
0.144
AC:
21918
AN:
152030
Hom.:
1581
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.164
Gnomad AMI
AF:
0.145
Gnomad AMR
AF:
0.168
Gnomad ASJ
AF:
0.190
Gnomad EAS
AF:
0.0776
Gnomad SAS
AF:
0.0944
Gnomad FIN
AF:
0.141
Gnomad MID
AF:
0.159
Gnomad NFE
AF:
0.134
Gnomad OTH
AF:
0.137
GnomAD2 exomes
AF:
0.139
AC:
34228
AN:
246470
AF XY:
0.136
show subpopulations
Gnomad AFR exome
AF:
0.166
Gnomad AMR exome
AF:
0.202
Gnomad ASJ exome
AF:
0.182
Gnomad EAS exome
AF:
0.0732
Gnomad FIN exome
AF:
0.149
Gnomad NFE exome
AF:
0.132
Gnomad OTH exome
AF:
0.136
GnomAD4 exome
AF:
0.131
AC:
181683
AN:
1390118
Hom.:
12454
Cov.:
22
AF XY:
0.130
AC XY:
90594
AN XY:
695782
show subpopulations
African (AFR)
AF:
0.170
AC:
5431
AN:
31938
American (AMR)
AF:
0.197
AC:
8746
AN:
44436
Ashkenazi Jewish (ASJ)
AF:
0.183
AC:
4692
AN:
25652
East Asian (EAS)
AF:
0.0859
AC:
3379
AN:
39346
South Asian (SAS)
AF:
0.101
AC:
8585
AN:
84858
European-Finnish (FIN)
AF:
0.142
AC:
7360
AN:
51856
Middle Eastern (MID)
AF:
0.180
AC:
954
AN:
5294
European-Non Finnish (NFE)
AF:
0.128
AC:
134751
AN:
1048794
Other (OTH)
AF:
0.134
AC:
7785
AN:
57944
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
8833
17667
26500
35334
44167
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4748
9496
14244
18992
23740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.144
AC:
21933
AN:
152148
Hom.:
1585
Cov.:
32
AF XY:
0.143
AC XY:
10663
AN XY:
74394
show subpopulations
African (AFR)
AF:
0.164
AC:
6821
AN:
41506
American (AMR)
AF:
0.168
AC:
2563
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.190
AC:
660
AN:
3470
East Asian (EAS)
AF:
0.0774
AC:
400
AN:
5168
South Asian (SAS)
AF:
0.0944
AC:
455
AN:
4818
European-Finnish (FIN)
AF:
0.141
AC:
1493
AN:
10594
Middle Eastern (MID)
AF:
0.154
AC:
45
AN:
292
European-Non Finnish (NFE)
AF:
0.134
AC:
9079
AN:
67994
Other (OTH)
AF:
0.135
AC:
285
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
956
1912
2867
3823
4779
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
234
468
702
936
1170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.134
Hom.:
1792
Bravo
AF:
0.150
Asia WGS
AF:
0.100
AC:
352
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 15, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
1.2
DANN
Benign
0.58
PhyloP100
-0.27
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3795575; hg19: chr1-204125089; COSMIC: COSV107237462; COSMIC: COSV107237462; API